Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Indonesia
  Ireland
  Israel
  Italy
  Jamaica
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malaysia
  Malta
  Mexico
  Montenegro
  Morocco
  Mozambique
  Namibia
  Netherlands
  New Zealand
  Nigeria
  Norway
  Panama
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Thailand
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States
  Vietnam


   Infocentre

Last Update: 19-06-2014  
Related category(ies):
Health & life sciences

 

Countries involved in the project described in the article:
Finland  |  France  |  Germany  |  Ireland  |  Netherlands  |  Sweden  |  United Kingdom  |  United States
Add to PDF "basket"

Treating seizures in newborn babies

During or just after birth many babies suffer from an inadequate intake of oxygen. Known as birth asphyxia this dangerous condition occurs in approximately 10 per 1,000 live births and is responsible for 23% of the 4 million newborn deaths worldwide each year.

Photo of a doctor examining a baby

© evgenyatamanenko - Fotolia.com

The lack of oxygen at birth is also an important cause of lifelong disabilities and learning difficulties. Many babies who experience birth asphyxia suffer fits (epileptic seizures) which can go unnoticed and can make the condition worse or cause additional brain damage.

The European Union (EU)-funded NEMO project brought together an international team of renowned experts to develop an effective drug that could treat seizures due to birth asphyxia and improve the long-term prospects of this vulnerable patient group.

Drug treatment for seizures in babies has not significantly changed over the last 50 years. The first choice drug worldwide is still Phenobarbitone, despite evidence that it is only effective in 30-50% of babies and might have side-effects on the brain development.

A key part of the five-year NEMO project is a series of Europe-wide multicentre studies to evaluate promising antiepileptic drugs suitable for use in newborn babies.

“The strength of NEMO project is the team which consists of scientists and clinicians with worldwide reputation, working together on the diagnosis and treatment of seizures in newborn babies,” says project coordinator Dr Ronit Pressler of the Great Ormond Street Hospital for Children, London, United Kingdom.

Integrating the latest scientific and technological advances in the field, the research team has applied various innovative methods to overcome the challenges in conducting clinical trials involving babies.

By monitoring the electrical activity of the brain - using EEG (electroencephalogram) technology - the NEMO team was able to accurately identify seizures and better monitor the progress of the treatment.

“The first clinical trial has finished and a larger trial is being planned to evaluate another promising drug for treating newborn babies suffering from seizures,” explains Dr Pressler.

In the words of Dr Pressler, the team is on target for developing a drug formulation suitable for newborn babies which can then be submitted for a Paediatric Use Marketing Authorisation (PUMA). “The development of new seizure drugs could potentially reduce infant deaths and minimise the lifetime economic and social impact,” concludes Dr Pressler.

10th February 2014 - European Epilepsy Day

 

Project details

  • Project acronym: NEMO
  • Participants: UK (Coordinator), France, Netherlands, Sweden, Germany, Ireland, USA, Finland
  • Project FP7 241479
  • Total costs: € 7 590 402
  • EU contribution: € 5 800 000
  • Duration: October 2009 - September 2014

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project web site
Project information on CORDIS






  Top   Research Information Center